Steffen Deichmann

6PUBLICATIONS
16CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 13, 2026
Octogenarians and Pancreatic Cancer: Is Surgery Always the Right Choice?

|Jun 13, 2025
Adjuvant Chemotherapy Is Associated with Improved Survival in Advanced Ampullary Adenocarcinoma-A Population-Based Analysis by the German Cancer Registry Group.

Jannis Duhn, Julia Strässer, Lennart von Fritsch

|Jun 19, 2024
Oncological Outcomes and Patterns of Recurrence after the Surgical Resection of an Invasive Intraductal Papillary Mucinous Neoplasm versus Primary Pancreatic Ductal Adenocarcinoma: An Analysis from the German Cancer Registry Group of the Society of German Tumor Centers.

Thaer S A Abdalla, Jannis Duhn, Monika Klinkhammer-Schalke

|Apr 09, 2022
Overexpression of integrin alpha 2 (ITGA2) correlates with poor survival in patients with pancreatic ductal adenocarcinoma.

Steffen Deichmann, Leif Schindel, Rüdiger Braun

|Jul 14, 2020
Alignment of stroma fibers, microvessel density and immune cell populations determine overall survival in pancreatic cancer-An analysis of stromal morphology.

Louisa Bolm, Petro Zghurskyi, Hryhoriy Lapshyn

|Apr 09, 2020
Systematic Analysis of Accuracy in Predicting Complete Oncological Resection in Pancreatic Cancer Patients-Proposal of a New Simplified Borderline Resectability Definition.

Louisa Bolm, Katharina Mueller, Katharina May

Pageof 1

Frequent Collaborators

3 joint publications

Ulrich Friedrich Wellner

3 joint publications

Sylke Ruth Zeissig

3 joint publications

Lennart von Fritsch

3 joint publications

Tobias Keck